Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Objective: The effect of bevacizumab on platinum sensitivity in recurrent ovarian cancer remains poorly understood. This study examined the association between platinum-free interval (PFI) and sensitivity to subsequent platinum-containing chemotherapy in patients with first relapsed ovarian cancer a...

Full description

Saved in:
Bibliographic Details
Main Authors: Tamaki Tanaka, Kazuhiro Takehara, Tomoka Usami, Masako Ishikawa, Eiji Kondo, Masahiro Kagabu, Kei Hirabayashi, Noriomi Matsumura, Shinya Sato, Masato Nishimura, Atsushi Arakawa, Keiichiro Nakamura, Yosuke Konno, Satoe Fujiwara, Kotaro Sueoka, Hiroko Nakamura, Iemasa Koh, Kimihiko Ito, Atsushi Hongo
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Gynecologic Oncology Reports
Subjects:
Ovarian cancer
Bevacizumab
Chemotherapy
Platinum-sensitive relapse
Platinum-free interval
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925000657
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2352578925000657

Similar Items